Skip to main navigation Skip to search Skip to main content

New Monoclonal Antibodies Findings from Stanford University Published (Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response)

Press/Media

PeriodSep 5 2025

Media coverage

1

Media coverage

  • TitleNew Monoclonal Antibodies Findings from Stanford University Published (Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date09/5/25
    PersonsSukhmani Kaur Padda